Cargando…

Computational study on novel natural compound inhibitor targeting IDH1_R132H

Isocitrate dehydrogenases (IDH) catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. IDH1 mutation has been reported in various tumors especially Cholangiocarcinoma, while the IDH1_R132H is reported to be the most common mutation of IDH1. IDH1_R132H inhibitors are effective anti-c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Baolin, Yang, Fang, Qin, Lei, Kuai, Jun, Yang, Lu, Zhang, Lanfang, Sun, Peisheng, Li, Guangpeng, Wang, Xinhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320544/ https://www.ncbi.nlm.nih.gov/pubmed/35802554 http://dx.doi.org/10.18632/aging.204162

Ejemplares similares

Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations
por: Tesileanu, C. Mircea S., et al.
Publicado: (2021)

Selected by bioinformatics and molecular docking analysis, Dhea and 2–14,15-Eg are effective against cholangiocarcinoma
por: Qin, Lei, et al.
Publicado: (2022)

Generation and Performance of R132H Mutant IDH1 Rabbit Monoclonal Antibody
por: Rashidian, Juliet, et al.
Publicado: (2017)

IDH1(R132H) Causes Resistance to HDAC Inhibitors by Increasing NANOG in Glioblastoma Cells
por: Kim, Geon-Hee, et al.
Publicado: (2019)

Decreased expression of IDH1-R132H correlates with poor survival in gastrointestinal cancer
por: Li, Jieying, et al.
Publicado: (2016)

Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas
por: Cai, Jinquan, et al.
Publicado: (2016)

Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype
por: Cuyàs, Elisabet, et al.
Publicado: (2015)

IDH1(R132H) in Neural Stem Cells: Differentiation Impaired by Increased Apoptosis
por: Rosiak, Kamila, et al.
Publicado: (2016)

IDH-1(R132H) mutation status in diffuse glioma patients: implications for classification
por: Wang, Peng-fei, et al.
Publicado: (2016)

R132H IDH1 sensitizes glioma to the antiproliferative and cytotoxic effects of BET inhibition
por: Sears, Thomas K., et al.
Publicado: (2022)

The prognostic IDH1(R132) mutation is associated with reduced NADP(+)-dependent IDH activity in glioblastoma
por: Bleeker, Fonnet E., et al.
Publicado: (2010)

Discovery and Validation of Novel LonP1 and Proteasome Inhibitor in IDH1-R132H Malignant Astrocytoma Models
por: Douglas, Christopher, et al.
Publicado: (2023)

Discovery of novel IDH1-R132C inhibitors through structure-based virtual screening
por: Hu, Chujiao, et al.
Publicado: (2022)

IDH1 R132H mutation regulates glioma chemosensitivity through Nrf2 pathway
por: Li, Kaishu, et al.
Publicado: (2017)

IDH1 p.R132 mutations may not be actively involved in the carcinogenesis of hepatocellular carcinoma
por: Lu, Jun, et al.
Publicado: (2014)

Characterization of an IDH1 R132H Rabbit Monoclonal Antibody, MRQ-67, and Its Applications in the Identification of Diffuse Gliomas
por: Copaciu, Raul, et al.
Publicado: (2023)

Effective immuno-targeting of the IDH1 mutation R132H in a murine model of intracranial glioma
por: Pellegatta, Serena, et al.
Publicado: (2015)

ATRX, IDH1-R132H and Ki-67 immunohistochemistry as a classification scheme for astrocytic tumors
por: Cai, Jinquan, et al.
Publicado: (2016)

IDH1 R132H Mutation Is Accompanied with Malignant Progression of Paired Primary-Recurrent Astrocytic Tumours
por: Mu, Luyan, et al.
Publicado: (2017)

IDH1(R132H) is intrinsically tumor-suppressive but functionally attenuated by the glutamate-rich cerebral environment
por: Tiburcio, Patricia D.B., et al.
Publicado: (2018)

Somatic Mosaicism of IDH1 R132H Predisposes to Anaplastic Astrocytoma: A Case of Two Siblings
por: Lee, Sulgi, et al.
Publicado: (2020)

LonP1 Drives Proneural Mesenchymal Transition in IDH1-R132H Diffuse Glioma
por: Douglas, Christopher, et al.
Publicado: (2023)

IDH1 R132C mutation is detected in clear cell hepatocellular carcinoma by pyrosequencing
por: Lee, Jung Hee, et al.
Publicado: (2017)

IDH1(R132H) Mutation Increases U87 Glioma Cell Sensitivity to Radiation Therapy in Hypoxia
por: Wang, Xiao-Wei, et al.
Publicado: (2014)

A heterozygous IDH1(R132H/WT) mutation induces genome-wide alterations in DNA methylation
por: Duncan, Christopher G., et al.
Publicado: (2012)

IDH1 R132H predicts sensitivity to Bcl-xL inhibition-mediated programmed cell death
por: Karpel-Massler, Georg, et al.
Publicado: (2017)

IDH1 Expression via the R132H Mutation–Specific Antibody in Adrenocortical Neoplasias—Prognostic Impact in Carcinomas
por: Pennanen, Mirkka, et al.
Publicado: (2020)

Nanomechanical Signatures in Glioma Cells Depend on CD44 Distribution in IDH1 Wild-Type but Not in IDH1R132H Mutant Early-Passage Cultures
por: Shmelev, Mikhail E., et al.
Publicado: (2023)

Low pH Facilitates Heterodimerization of Mutant Isocitrate Dehydrogenase IDH1-R132H and Promotes Production of 2-Hydroxyglutarate
por: Sesanto, Rae, et al.
Publicado: (2021)

IDH1(R132H) decreases the proliferation of U87 glioma cells through upregulation of microRNA-128a
por: NIE, QUAN-MIN, et al.
Publicado: (2015)

Somatic IDH1 variant (p.R132C) in an adult male with Maffucci syndrome
por: Brown, Natasha J., et al.
Publicado: (2021)

Expression of Idh1(R132H) in the Murine Subventricular Zone Stem Cell Niche Recapitulates Features of Early Gliomagenesis
por: Bardella, Chiara, et al.
Publicado: (2016)

Lack of B and T cell reactivity towards IDH1(R132H) in blood and tumor tissue from LGG patients
por: Weenink, Bas, et al.
Publicado: (2019)

Association of The IDH1 C.395G>A (R132H) Mutation with Histological Type in Malay Brain Tumors
por: Yusoff, Abdul Aziz Mohamed, et al.
Publicado: (2016)

Generation of induced neural stem cells with inducible IDH1(R132H) for analysis of glioma development and drug testing
por: Rosiak-Stec, Kamila, et al.
Publicado: (2020)

IDH1-R132H mutation radiosensitizes U87MG glioma cells via epigenetic downregulation of TIGAR
por: Yin, Narui, et al.
Publicado: (2020)

High EZH2 Protein Expression Is a Poor Prognostic Predictor in IDH1 R132H-Negative Gliomas
por: Wong, Yin Ping, et al.
Publicado: (2022)

A Rare Co-Occurrence of Maffucci Syndrome and Astrocytoma with IDH1 R132H Mutation: A Case Report
por: Ashirov, Nurali, et al.
Publicado: (2023)

Computational study on natural compounds inhibitor of c-Myc
por: Ren, Junan, et al.
Publicado: (2020)

IDH1-R132 changes vary according to NPM1 and other mutations status in AML
por: Falini, Brunangelo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jmp1timfjfcfugoic2jiq0jqk8